Swedish Orphan (Sweden) Profile

118.3
SEK 0.3  0.25%
116.6Last Month High 126.2 
117.5Trading Day  High 118.8 
Advice Valuation
October 23, 2017 updated few hours ago

Swedish Orphan Summary

Swedish Orphan Biovitrum AB (SOBI) is traded on Stockholm Stock Exchange in Sweden. It is located in Stockholm, and employs 702 people. The company currently falls under 'Large-Cap' category with current market capitalization of 33.91 B. Swedish Orphan Biovitrum AB operates under Healthcare sector and is part of Medical Laboratories and Research industry. This company has 271.24 M outstanding shares. SWE ORPHAN BIOVIT has accumulated about 1.19 B in cash with 604.86 M of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 4.42.
Check Swedish Orphan Probability Of Bankruptcy

Swedish Orphan Biovi Risk Profiles

Key Fundamentals

Swedish Orphan Against Markets

Current Ratings  

Swedish Orphan 30 Days Performance Scores
Risk Adjusted
Performance Score (0 to 100)
0 
Chance of
< 2% 
Swedish Orphan Biovitrum AB , an integrated biopharmaceutical company, researches, develops, manufactures, and sells pharmaceuticals in the therapeutic areas of haemophilia, inflammation, and genetics and metabolism diseases primarily in Europe and North America. more
NameSwedish Orphan Biovitrum AB
Macroaxis Advice
Specialization
Healthcare, Pharmaceuticals And Biosciences
InstrumentSweden Stock Stocks Directory
Business AddressStockholm,
ExchangeStockholm Stock Exchange
ISINSE0000872095
SectorHealthcare
IndustryMedical Laboratories and Research
BenchmarkDOW
Websitewww.sobi.com
Contact Number46 86 97 20 00
CurrencySEK - Swedish Kronor

Opportunities

Explore Investment Opportunities
Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked.
Explore Investing Ideas